Mirum scores second FDA nod for rare liver disease drug Livmarli, this one to treat PFIC
Mirum scores second FDA nod for rare liver disease drug Livmarli, this one to treat PFIC kdunleavy Wed, 03/13/2024 - 14:52
Mirum scores second FDA nod for rare liver disease drug Livmarli, this one to treat PFIC kdunleavy Wed, 03/13/2024 - 14:52
Aurobindo unit begins shipping drugs from India plant after FDA inspection triggered production halt jkeenan Wed, 03/13/2024 - 11:53
Skincare products maker Galderma gears up for long-awaited $2.6B IPO zbecker Wed, 03/13/2024 - 11:19
J&J's Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings kdunleavy Wed, 03/13/2024 - 10:48
FDA flags early deaths in CAR-T myeloma trials for J&J and Legend’s Carvykti, Bristol Myers’ Abecma aliu Wed, 03/13/2024 - 10:24
Takeda winds down manufacturing and R&D operations in Austria after gene therapy pivot, plots 190 layoffs fkansteiner Wed, 03/13/2024 - 09:44